What are the most common primary and secondary brain tumors in adults?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 23, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Common Brain Tumors in Adults

Metastatic brain tumors are the most common intracranial tumors in adults, occurring approximately 10 times more frequently than primary brain tumors, with lung cancer accounting for half of all brain metastases. 1

Primary Brain Tumors

Most Common Primary Tumors

Meningioma is the single most common primary brain tumor in adults overall, accounting for approximately 40% of all primary CNS tumors. 1

  • Meningiomas show strong female predominance with a 2:1 to 3:1 female-to-male ratio 2
  • These tumors become increasingly common from age 35 years onward and remain the leading primary brain tumor through old age 2
  • Most meningiomas (75-80%) are CNS WHO grade 1 (benign), with 15-20% being grade 2 and only 1-5% being grade 3 1

Most Common Malignant Primary Tumors

Glioblastoma (grade IV astrocytoma) is the most common primary malignant brain tumor in adults, accounting for 54% of all gliomas. 1

  • Glioblastoma is the most lethal brain tumor, with only one-third of patients surviving 1 year and fewer than 5% living beyond 5 years 1
  • The vast majority (90%) are IDH-wildtype, corresponding to de novo glioblastomas arising after age 55 years 3
  • These tumors typically present with rapidly progressive symptoms over weeks to months, including increased intracranial pressure, seizures, or focal neurologic deficits 1

Anaplastic astrocytomas (grade III) are the second most common malignant glioma, accounting for 7% of all gliomas, with a 5-year survival rate of 27%. 1

Other Notable Primary Tumors

Pituitary adenomas represent another common benign primary brain tumor, particularly in younger adults transitioning from adolescence. 2, 4

  • Together with meningiomas and vestibular schwannomas (acoustic neuromas), these benign tumors account for 30-40% of primary brain tumors 4

Anaplastic oligodendrogliomas are relatively rare but have a much better prognosis than anaplastic astrocytomas and glioblastomas, with half of patients alive at 5 years, due to marked sensitivity to chemotherapy and characteristic allelic losses of chromosomes 1p and 19q. 1

Secondary (Metastatic) Brain Tumors

Epidemiology and Sources

Brain metastases affect 8-10% of patients with cancer and occur in an estimated 20-40% of patients with systemic cancer. 1

Primary lung cancers are the most common source of brain metastases, accounting for half of all intracranial metastases, though melanoma has the highest predilection to spread to the brain. 1

  • Breast cancer is increasingly diagnosed with CNS involvement as systemic therapies improve 1

Distribution Patterns

Nearly 80% of brain metastases occur in the cerebral hemispheres, 15% in the cerebellum, and 5% in the brainstem. 1

  • These lesions typically follow hematogenous spread to the gray-white junction where narrow blood vessels trap tumor emboli 1
  • Most cases have multiple brain metastases evident on MRI 1

Age-Related Considerations

The incidence of primary brain tumors has been increasing over the past 30 years, especially in elderly persons. 1

  • In young adults (age 20-34 years), medulloblastoma accounts for only 2% of CNS tumors, making it far less common than meningioma 2
  • Glioblastoma becomes the second most common tumor (after meningioma) from middle age onward 2
  • Pediatric tumors like pilocytic astrocytoma and medulloblastoma are characteristic of children and adolescents, not adults 2

Key Prognostic Factors

For high-grade gliomas, the most important prognostic factors are histologic diagnosis, age, and performance status. 1

  • Age over 55 years is a significant negative prognostic variable for glioblastoma 5
  • IDH-mutant glioblastomas predominate in younger adults and have prolonged survival compared to IDH-wildtype tumors 3

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Most Common Brain Tumor in Young Adults

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Thalamic Tumors in Adults

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Medial Frontal Lobe Masses in Elderly Males

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Related Questions

What is the appropriate treatment for a benign brain tumor?
What is the recommended treatment approach for managing disease progression in patients with brain tumors?
What defines a brain tumor as terminal?
Could a patient with a complex medical history, depression, anxiety, neuropathic pain, and cognitive impairment, currently taking Prozac (fluoxetine) and duloxetine, have a brain tumor?
What are the treatment options for a brain tumor causing vision loss in one eye?
What are the typical metastatic sites and pattern of spread for endometrial cancer?
What is the safest evidence‑based first‑line medication for treating hypersexual (disinhibited sexual) behavior in older adults with dementia?
In a 52‑year‑old patient with peripheral edema, macrocytosis (MCV 101 fL), mildly elevated aspartate aminotransferase (AST 124 U/L) and alanine aminotransferase (ALT 71 U/L), fasting glucose 136 mg/dL, severe vitamin D deficiency (25‑hydroxy‑vitamin D 14 ng/mL), mild dyslipidemia (total cholesterol 222 mg/dL, HDL 114 mg/dL, LDL 93 mg/dL), normal renal function, normal albumin, normal thyroid function, and low B‑type natriuretic peptide (BNP 3 pg/mL), what are the most likely contributors to the edema and what initial evaluation and management steps should be taken?
In a patient undergoing PCI in the cath lab who is already receiving dopamine and norepinephrine infusions, can low‑dose phenylephrine be added to support norepinephrine according to current guidelines?
What are the recommended treatments for xerostomia (dry mouth)?
Can letrozole (aromatase inhibitor) cause a false‑positive urine luteinizing hormone (LH) ovulation test in women undergoing ovulation induction?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.